Equities

abrdn Healthcare Investors

HQH:NYQ

abrdn Healthcare Investors

Actions
FinancialsClosed End Investments
  • Price (USD)16.13
  • Today's Change0.01 / 0.06%
  • Shares traded127.77k
  • 1 Year change-8.77%
  • Beta0.7384
Data delayed at least 15 minutes, as of Apr 24 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.

  • Revenue in USD (TTM)10.29m
  • Net income in USD56.33m
  • Incorporated1986
  • Employees--
  • Location
    abrdn Healthcare Investors1900 Market Street, Suite 200PHILADELPHIA 19103United StatesUSA
  • Phone+1 (617) 772-8515
  • Websitehttps://www.abrdnhqh.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PIMCO High Income Fund-100.00bn-100.00bn722.38m--------------------------------------------------------------
DoubleLine Yield Opportunities Fund86.97m60.21m726.86m--12.071.01--8.361.261.261.8115.080.0929--5.28--6.43--6.46--71.76--69.23----33.870.2038--4.26--134.92------
Blackrock Muniyield Quality Fund III Inc59.31m24.80m727.15m--29.310.8626--12.260.37320.37320.889618.040.0426--2.57--1.781.191.801.2052.5167.8341.8132.00--5.290.0997207.594.73-2.6998.11-----7.65
Western Asset Diversified Income Fund127.11m124.84m728.14m--5.830.9049--5.732.412.412.4515.540.1086--30.93--10.67--15.88--71.46--98.21------0.3079--17.69--169.63------
Copper Property CTL Pass Through Trust101.58m69.16m733.50m--10.610.67068.307.220.92220.92221.3514.580.0802--2.47--5.46--5.63--93.47--68.09------0.00---6.29---20.97------
Nuveen Credit Strategies Income Fund-100.00bn-100.00bn740.43m--------------------------------------------------------------
Redwood Trust Inc759.58m-12.96m751.78m289.00--0.661127.510.9897-0.1205-0.12056.529.150.0552--5.302,628,301.00-0.0165-0.3735-0.0193-0.434614.9420.87-0.2994-8.00--1.200.9156--7.3114.9392.28-----9.66
abrdn Healthcare Investors10.29m56.33m779.42m--13.560.8558--75.731.191.190.208218.840.0111--2.12--6.062.256.102.26-2.45-27.22547.37272.24----0.00359.1724.448.69129.00-4.03----
BlackRock Resources&Commdts Strtgy Trst34.23m-8.64m783.89m----0.8641--22.90-0.0919-0.09190.405810.570.036--8.13---0.90889.71-0.91029.7572.6773.37-25.23263.45--0.73860.0058.80-5.37-16.64-106.28----0.0774
abrdn Healthcare Opportunities Fund23.60m52.79m792.80m--15.020.9523--33.601.281.280.570620.130.0222--8.70--4.964.284.984.35-8.0714.23223.69217.62----0.2128118.4030.08-0.4309161.20-11.25---2.93
Cornerstone Total Return Fund Inc-100.00bn-100.00bn801.21m--------------------------------------------------------------
Calamos Convertible Opprtnts nd Incm Fnd-100.00bn-100.00bn812.77m--------------------------------------------------------------
BlackRock Enhancd Cptl And Incm Fund Inc-100.00bn-100.00bn813.80m0.00------------------------------------------------------------
Abrdn Total Dynamic Dividend Fund-100.00bn-100.00bn829.74m--------------------------------------------------------------
SLR Investment Corp229.31m76.39m829.78m0.0010.860.841--3.621.401.404.2018.090.0906--9.89--3.022.143.592.6444.8149.8233.3127.44--5.860.5442167.6529.198.36316.462.70--0.0004
Blackrock Municipal Income Fund Inc68.10m24.26m836.55m--34.470.8694--12.280.33710.33710.944821.160.0419--14.87--1.49--1.51--48.15--35.63----4.190.0327--------------
Data as of Apr 24 2024. Currency figures normalised to abrdn Healthcare Investors's reporting currency: US Dollar USD

Institutional shareholders

18.31%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 20233.02m6.25%
Saba Capital Management LPas of 13 Mar 20242.56m5.29%
Cornerstone Advisors LLC (North Carolina)as of 31 Dec 2023732.30k1.52%
AQR Arbitrage LLCas of 31 Dec 2023500.42k1.04%
RBC Capital Markets LLC (Investment Management)as of 31 Dec 2023459.51k0.95%
RPO LLCas of 31 Dec 2023382.49k0.79%
Clough Capital Partners LPas of 31 Dec 2023323.23k0.67%
Boothbay Fund Management LLCas of 31 Dec 2023312.25k0.65%
Logan Stone Capital LLCas of 31 Dec 2023297.29k0.62%
Eschler Asset Management LLPas of 31 Dec 2023263.56k0.55%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.